Archives

Depression & Anxiety In End-Stage Kidney Disease
About This Event
Depression & Anxiety In End-Stage Kidney Disease
This presentation will illuminate the burden of depression and anxiety in ESKD patients and the associated risk factors. Best practices and strategies for recognizing and discussing these concerns with patients will be shared.
Ferrari’s Italian Villa & Chop House
Grapevine, TX 76051 United States + Google Map
Featuring

Molly Jansen, PhD
Dr Molly Jansen is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.

Nneka Okonkwor, PharmD, MBA
Molly Jansen, PhD and Nneka Okonkwor, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)